Capsaicin blocks HIV protease inhibitor ritonavir - Induced vascular dysfunction in porcine pulmonary arteries

Medical Science Monitor

Volumn 15, Issue 1, 2009, Pages

  Dhadwal, Ajay K ^a   Wang, Xinwen ^a   Annambhotla, Suman ^a   Lin, Peter H ^a,b   Yao, Qizhi ^a,b   Chen, Changyi ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Capsaicin; HIV protease inhibitor; Porcine pulmonary arteries; Pulmonary artery hypertension; Ritonavir; Vascular dysfunction; Vasomotor

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; BRADYKININ; CAPSAICIN; NITROPRUSSIDE SODIUM; RITONAVIR;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTERY CONSTRICTION; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG INHIBITION; DRUG RESPONSE; ENDOTHELIUM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS; MYOGRAPHY; NONHUMAN; PULMONARY ARTERY; PULMONARY VASCULAR DISEASE; SWINE; VASODILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANALYSIS OF VARIANCE; ANIMALS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRADYKININ; CAPSAICIN; ELECTROMYOGRAPHY; NITROPRUSSIDE; PERIPHERAL VASCULAR DISEASES; PULMONARY ARTERY; RITONAVIR; SWINE; VASODILATION;

EID: 58649100449     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. United States Centers for Disease Control and Prevention: HIV/AIDS United States, 1981-2006. MMWR Morb Mortal Wkly Rep, 2006; 55: 588-605
2. Crum NF, Riffenburgh RH, Wegner S et al: Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART eras. J Acquir Immune Defic Syndr, 2006; 41: 194-200
3. Lewden C, Salmon D, Morlat P et al: Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol, 2005; 34: 121-30
4. Speich R, Jenni R, Opravil M et al: Primary pulmonary hypertension in HIV infection. Chest, 1991; 100: 1268-71
5. Pugliese A, Isnardi D, Saini A et al: of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect, 2000: 40; 282-84
6. Pellicelli AM, Palmieri F, D'Ambrosio C et al: Role of human immunodeficiency virus in primary pulmonary hypertension - case reports. Angiology, 1998; 49: 1005-11
7. The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group: Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med, 2003; 349: 1993-2003
8. Rhew DC, Bernal M, Aguilar D et al: Association between protease inhibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus: a systematic review. Clin Infect Dis, 2003; 37: 959-72
9. Calza L, Manfredi R, Chiodo F: Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management. Int J Antimicrob Agents, 2003; 22: 89-99
10. Stein JH, Klein MA, Bellehumeur JL et al: Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation, 2001; 104: 257-62
11. Ahuja KD, Ball MJ: Effects of daily ingestion of chili on serum lipoprotein oxidation in adult men and women. Br J Nutr, 2006; 96: 239-44
12. Materska M, Perucka I: Antioxidant Activity of the Main Phenolic Compounds Isolated from Hot Pepper Fruit (Capsicum annuum L.). J Agric Food Chem, 2005; 53: 1750-56
13. Han SS, Keum YS, Seo HJ et al: Capsaicin suppresses phorbol ester-induced activation of NF-kappaB/Rel and AP-1 transcription factors in mouse epidermis. Cancer Lett, 2001; 164: 119-26
14. Kim CS, Kawada T, Kim BS et al: Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal macrophages. Cell Signal, 2003; 15: 299-306
15. Palella FJ Jr, Delaney KM, Moorman AC et al: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection HIV Outpatient Study Investigators. N Engl J Med, 1998; 338: 8536-40
16. Cotter BR, Torriani FJ: Cardiovascular effects of antiretroviral therapy and noninvasive assessments of cardiovascular disease in HIV infection. Cardiovasc Toxicol, 2004; 4: 281-86
17. Wang X, Chai H, Yao Q, Chen C: Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction. J Acquir Immune Defic Syndr, 2007; 44: 493-99
18. Nedeljkovic ZS, Gokce N, Loscalzo J: Mechanisms of oxidative stress and vascular dysfunction. Postgrad Med J, 2003; 79: 195-99
19. Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res, 2000; 87: 840-44
20. Wilcox JN, Subramanian RR, Sundell CL et al: Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol, 1997; 17: 2479-88
21. Berka V, Tsai AL: Characterization of interactions among the heme center, tetrahydrobiopterin, and L-arginine binding sites of ferric eNOS using imidazole, cyanide, and nitric oxide as probes. Biochemistry, 2000; 39: 9373-83
22. Pou S, Pou WS, Bredt DS et al: Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem, 1992; 267: 24173-76
23. Shimokawa H, Flavahan NA, Vanhoutte PM: Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries. Circulation, 1991; 83: 652-60
24. Harrison DG: Endothelial function and oxidant stress. Clin Cardiol, 1997; 20: II11-17
25. Ahuja KD, Robertson IK, Geraghty DP, Ball MJ: The effect of 4-week chilli supplementation on metabolic and arterial function in humans. Eur J Clin Nutr, 2007; 61: 326-33
26. Shimeda Y, Hirotani Y, Akimoto Y et al: Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. 2005; 28: 1635-38
27. Brar SS, Kennedy TP, Whorton AR et al: Reactive oxygen species from NAD(P)H: quinone oxidoreductase constitutively activate NF-kappaB in malignant melanoma cells. Am J Physiol Cell Physiol, 2001; 280: C659-76